IBDEI21C ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34102,0)
 ;;=M32.14^^154^1723^2
 ;;^UTILITY(U,$J,358.3,34102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34102,1,3,0)
 ;;=3^Glomerular disease in systemic lupus erythematosus
 ;;^UTILITY(U,$J,358.3,34102,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,34102,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,34103,0)
 ;;=M32.15^^154^1723^13
 ;;^UTILITY(U,$J,358.3,34103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34103,1,3,0)
 ;;=3^Tubulo-interstitial neuropathy in SLE
 ;;^UTILITY(U,$J,358.3,34103,1,4,0)
 ;;=4^M32.15
 ;;^UTILITY(U,$J,358.3,34103,2)
 ;;=^5011758
 ;;^UTILITY(U,$J,358.3,34104,0)
 ;;=M34.0^^154^1723^12
 ;;^UTILITY(U,$J,358.3,34104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34104,1,3,0)
 ;;=3^Progressive systemic sclerosis
 ;;^UTILITY(U,$J,358.3,34104,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,34104,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,34105,0)
 ;;=Z87.442^^154^1724^1
 ;;^UTILITY(U,$J,358.3,34105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34105,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,34105,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,34105,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,34106,0)
 ;;=N20.0^^154^1724^2
 ;;^UTILITY(U,$J,358.3,34106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34106,1,3,0)
 ;;=3^Calculus of Kidney
 ;;^UTILITY(U,$J,358.3,34106,1,4,0)
 ;;=4^N20.0
 ;;^UTILITY(U,$J,358.3,34106,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,34107,0)
 ;;=N20.1^^154^1724^3
 ;;^UTILITY(U,$J,358.3,34107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34107,1,3,0)
 ;;=3^Calculus of Ureter
 ;;^UTILITY(U,$J,358.3,34107,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,34107,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,34108,0)
 ;;=N20.2^^154^1724^4
 ;;^UTILITY(U,$J,358.3,34108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34108,1,3,0)
 ;;=3^Calculus of Kidney w/ Calculus of Ureter
 ;;^UTILITY(U,$J,358.3,34108,1,4,0)
 ;;=4^N20.2
 ;;^UTILITY(U,$J,358.3,34108,2)
 ;;=^5015609
 ;;^UTILITY(U,$J,358.3,34109,0)
 ;;=N20.9^^154^1724^5
 ;;^UTILITY(U,$J,358.3,34109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34109,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,34109,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,34109,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,34110,0)
 ;;=E72.53^^154^1724^6
 ;;^UTILITY(U,$J,358.3,34110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34110,1,3,0)
 ;;=3^Hyperoxaluria
 ;;^UTILITY(U,$J,358.3,34110,1,4,0)
 ;;=4^E72.53
 ;;^UTILITY(U,$J,358.3,34110,2)
 ;;=^60210
 ;;^UTILITY(U,$J,358.3,34111,0)
 ;;=R78.89^^154^1725^1
 ;;^UTILITY(U,$J,358.3,34111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34111,1,3,0)
 ;;=3^Lithium Toxicity
 ;;^UTILITY(U,$J,358.3,34111,1,4,0)
 ;;=4^R78.89
 ;;^UTILITY(U,$J,358.3,34111,2)
 ;;=^5019588
 ;;^UTILITY(U,$J,358.3,34112,0)
 ;;=99211^^155^1726^1
 ;;^UTILITY(U,$J,358.3,34112,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34112,1,2,0)
 ;;=2^99211
 ;;^UTILITY(U,$J,358.3,34112,1,3,0)
 ;;=3^RN/LPN Visit
 ;;^UTILITY(U,$J,358.3,34113,0)
 ;;=99212^^155^1726^2
 ;;^UTILITY(U,$J,358.3,34113,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34113,1,2,0)
 ;;=2^99212
 ;;^UTILITY(U,$J,358.3,34113,1,3,0)
 ;;=3^Problem Focused
 ;;^UTILITY(U,$J,358.3,34114,0)
 ;;=99213^^155^1726^3
 ;;^UTILITY(U,$J,358.3,34114,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34114,1,2,0)
 ;;=2^99213
 ;;^UTILITY(U,$J,358.3,34114,1,3,0)
 ;;=3^Exp Prob Focused
 ;;^UTILITY(U,$J,358.3,34115,0)
 ;;=99214^^155^1726^4
 ;;^UTILITY(U,$J,358.3,34115,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34115,1,2,0)
 ;;=2^99214
 ;;^UTILITY(U,$J,358.3,34115,1,3,0)
 ;;=3^Detailed
 ;;^UTILITY(U,$J,358.3,34116,0)
 ;;=99215^^155^1726^5
